Veradermics is trading at $106.75, down 4.1%, in an apparent pullback following a week of sharp gains and losses.

  • The move occurs in the absence of fresh company-specific news, earnings releases, or major analyst calls.
  • Shares have seen high volatility over the past week, marked by double-digit swings in both directions.
  • The decline comes against a mixed broader market backdrop where major indices are only modestly changed.